Core Insights - Wuxi aims to develop four major city brands: Industrial Science and Technology City, Lake Bay Ecological City, Open Hub City, and Jiangnan Cultural City over the next five years [1] - The city has achieved significant economic milestones during the 14th Five-Year Plan, including a GDP increase crossing four trillion yuan thresholds and a per capita GDP surpassing $30,000 [1] - Wuxi's industrial output value exceeded 2.7 trillion yuan, and the total scale of modern industrial clusters surpassed 1.88 trillion yuan, with a technology progress contribution rate expected to rank first in the province for 13 consecutive years [1] Economic Development - Wuxi plans to focus on eight key areas: expanding domestic demand, strengthening the real economy, leading through innovation, reform and opening up, multi-dimensional integration, green transformation, prioritizing people's livelihoods, and ensuring safety [2] - The city aims to complete over 150 billion yuan in major industrial project investments and implement more than 650 projects with an investment of over 10 million yuan each [2] - Wuxi intends to create 150 typical "AI + manufacturing" scenarios and execute 100 key technology research and development projects to enhance its global market share [2]

Group 1: Company Fundraising and Investment - Company plans to use 500 million yuan of raised funds to increase capital in its wholly-owned subsidiaries for the implementation of a DRAM investment project [1] - Zhuhai Hengqin Chip Storage Co., Ltd. will receive 30 million yuan, and Hefei Chip Storage Co., Ltd. and Xi'an Chip Storage Co., Ltd. will receive 50 million yuan and 30 million yuan respectively for the DRAM project [1] Group 2: Profit Forecasts and Turnarounds - Yiling Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan in 2025, recovering from a loss of 725 million yuan in the previous year [2] - Liard anticipates a net profit of 300 million to 380 million yuan in 2025, compared to a loss of 889 million yuan last year, driven by a new strategic cycle focusing on AI [2] - Daming City forecasts a net profit of 140 million to 165 million yuan in 2025, recovering from a loss in the previous year, aided by reduced asset impairment losses [3] - Guanghua Technology expects a net profit of 85 million to 120 million yuan in 2025, recovering from a loss of 205 million yuan last year, due to expansion in specialized chemicals and PCB sectors [3] - Boteng Co. anticipates a net profit of 80 million to 105 million yuan in 2025, recovering from a loss of 288 million yuan, supported by operational efficiency improvements [4] - Shiyida expects a net profit of 31 million to 46 million yuan in 2025, recovering from a loss of 2.34 million yuan last year, driven by business development and cost control [4] - Guochuang High-tech forecasts a net profit of 16 million to 24 million yuan in 2025, recovering from a loss of 49 million yuan, aided by improved receivables management [5][6] Group 3: Share Buybacks - Hengyi Petrochemical plans to repurchase shares with a total fund of no less than 500 million yuan and no more than 1 billion yuan, with a maximum price of 15 yuan per share [7] - Yunyi Electric plans to repurchase shares with a total fund of no less than 100 million yuan and no more than 150 million yuan, with a maximum price of 17 yuan per share [7] - Xidian Pharmaceutical intends to repurchase shares with a total fund of no less than 25 million yuan and no more than 50 million yuan, with a maximum price of 42 yuan per share [7] Group 4: Performance Highlights - Te Yi Pharmaceutical expects a net profit of 70 million to 90 million yuan in 2025, a growth of 241.55% to 339.13% year-on-year [8] - Xingqi Eye Medicine anticipates a net profit of 662 million to 749 million yuan in 2025, a growth of 95.82% to 121.56% year-on-year [8] - Tianhe Co. forecasts a net profit of 41 million to 60 million yuan in 2025, a growth of 84.35% to 169.78% year-on-year [8] - Ruichuang Micro-Nano expects a net profit of approximately 1.1 billion yuan in 2025, a 93% increase year-on-year [9] - Zhongyuan Co. anticipates a net profit of 139 million to 158 million yuan in 2025, a growth of 80% to 105% year-on-year [9] Group 5: Important Corporate Developments - Aolaide has received acceptance for its application to issue securities on the Science and Technology Innovation Board [14] - *ST Songfa's subsidiary signed contracts for the construction of two VLCC super-large oil tankers, expected to positively impact future performance [15] - Chongda Technology's subsidiary signed an investment agreement for a 1 billion yuan IC packaging project in Jiangsu Province [15] - Yinglian Co. signed a strategic agreement with LG Chem to establish a joint laboratory for innovative materials in lithium battery applications [16]

Group 1 - ShenNan Electric A expects a net profit increase of 584.66%-721.59% year-on-year for 2025 [1] - Te Yi Pharmaceutical anticipates a net profit increase of 241.55%-339.13% year-on-year for 2025 [1] - RunTu Co. forecasts a net profit increase of 181.05%-227.89% year-on-year for 2025 [1] - QingSong Co. projects a net profit increase of 137.73%-201.74% year-on-year for 2025 [1] - RuiSheng Intelligent expects a net profit increase of 112.00%-139.99% year-on-year for 2025 [1] - JianKai Technology anticipates a net profit increase of 101.09%-121.20% year-on-year for 2025 [1] - XingQi Eye Medicine forecasts a net profit increase of 95.82%-121.56% year-on-year for 2025 [1] - RuiChuang MicroNano expects a net profit increase of approximately 93% year-on-year for 2025 [1] - TianHe Co. projects a net profit increase of 84.35%-169.78% year-on-year for 2025 [1] - ZhongYuan Co. anticipates a net profit increase of 80%-105% year-on-year for 2025 [1] - YiDao Information expects a net profit increase of 76.04%-128.85% year-on-year for 2025 [1] - ShengDa Bio forecasts a net profit increase of 69.93%-120.90% year-on-year for 2025 [1] - HuaRui Precision anticipates a net profit increase of 68.29%-86.99% year-on-year for 2025 [1] - FangZheng Technology expects a net profit increase of 67.06%-98.14% year-on-year for 2025 [1] - JinLing Hotel projects a net profit increase of 65.37%-90.93% year-on-year for 2025 [1] - QiangYi Co. anticipates a net profit increase of 57.87%-71.17% year-on-year for 2025 [1] - LangBo Technology expects a net profit increase of 57.58%-66.53% year-on-year for 2025 [1] - HuaFeng Measurement and Control forecasts a net profit increase of 46%-78% year-on-year for 2025 [1] - Zhaoyi Innovation anticipates a net profit increase of approximately 46% year-on-year for 2025 [1] - JieChang Drive expects a net profit increase of 40%-55% year-on-year for 2025 [1] - ShengYuan Environmental Protection projects a net profit increase of 31.79%-59.24% year-on-year for 2025 [1] - GuangHa Communication anticipates a net profit increase of 21.83%-31.31% year-on-year for 2025 [1] - MaiHe Co. expects a net profit increase of 19.58%-54.76% year-on-year for 2025 [1] Group 2 - YiLing Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan for 2025, turning profitable year-on-year [1] - LiYade anticipates a net profit of 300 million to 380 million yuan for 2025, turning profitable year-on-year [1] - SiRuiPu expects a net profit of 165 million to 184 million yuan for 2025, turning profitable year-on-year [1] - DaMing City anticipates a net profit of 140 million to 165 million yuan for 2025, turning profitable year-on-year [1] - DaHeng Technology expects a net profit of 106 million yuan for 2025, turning profitable year-on-year [1] - GuangHua Technology projects a net profit of 85 million to 120 million yuan for 2025, turning profitable year-on-year [1] - BoTeng Co. expects a net profit of 80 million to 105 million yuan for 2025, turning profitable year-on-year [2] - ZhongBing HongJian anticipates a net profit of 34 million to 46 million yuan for 2025, turning profitable year-on-year [2]

报告期内公司计提资产减值损失的金额同比2024年大幅减少，主要系影响公司计提存货跌价准备及投资 性房地产减值准备的因素已不再持续恶化。 报告期内公司依据杭州普润星融股权投资合伙企业(有限合伙)出具的《杭州星融有限合伙人减资退伙清 算分配通知书》，公司已完成该项投资的全部退出及收回工作，已全额收到投资款8.048亿。本投资事 项的完成，导致公司本报告期的投资收益增加。 大名城（600094）(600094.SH)发布2025年度业绩预告，预计公司2025年度实现归属母公司所有者的净 利润约为1.4亿元至1.65亿元，与上年同期相比，将实现扭亏为盈。 ...

智通财经APP讯，大名城(600094.SH)发布2025年度业绩预告，预计公司2025年度实现归属母公司所有 者的净利润约为1.4亿元至1.65亿元，与上年同期相比，将实现扭亏为盈。 报告期内公司依据杭州普润星融股权投资合伙企业(有限合伙)出具的《杭州星融有限合伙人减资退伙清 算分配通知书》，公司已完成该项投资的全部退出及收回工作，已全额收到投资款8.048 亿。本投资事 项的完成，导致公司本报告期的投资收益增加。 报告期内公司计提资产减值损失的金额同比2024年大幅减少，主要系影响公司计提存货跌价准备及投资 性房地产减值准备的因素已不再持续恶化。 ...

格隆汇1月22日丨大名城(600094.SH)公布，经财务部门初步测算，预计公司2025年度实现归属母公司所 有者的净利润约为1.4亿元至1.65亿元，与上年同期相比，将实现扭亏为盈。预计2025年度实现归属于母 公司所有者的扣除非经常性损益后的净利润约为1.35亿元至1.6亿元。 ...

(本文来自第一财经) 大名城公告，经财务部门初步测算，预计公司2025年度实现归属母公司所有者的净利润约为1.4亿元至 1.65亿元，与上年同期相比，将实现扭亏为盈。预计2025年度实现归属于母公司所有者的扣除非经常性 损益后的净利润约为1.35亿元至1.6亿元。 ...

每经AI快讯，大名城1月22日晚间发布业绩预告，预计公司2025年度实现归属母公司所有者的净利润约 为1.4亿元至1.65亿元，与上年同期相比，将实现扭亏为盈。业绩变动主要原因是，报告期内公司计提资 产减值损失的金额同比2024年大幅减少，主要系影响公司计提存货跌价准备及投资性房地产减值准备的 因素已不再持续恶化。报告期内公司依据杭州普润星融股权投资合伙企业（有限合伙）出具的《杭州星 融有限合伙人减资退伙清算分配通知书》，公司已完成该项投资的全部退出及收回工作，已全额收到投 资款8.048亿。本投资事项的完成，导致公司本报告期的投资收益增加。 （记者 王晓波） 每经头条（nbdtoutiao）——特朗普强要格陵兰岛，丹麦一养老基金率先清仓美债，美国资产全线下 跌！欧洲手握"金融核按钮"，双方会"鱼死网破"吗？专家解读→ ...

本公司董事局及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 股票代码：600094、900940 股票简称：大名城、大名城B 编号：2026-002 上海大名城企业股份有限公司 2025 年度业绩预告的公告 重要内容提示： 业绩预告的具体适用情形：净利润实现扭亏为盈。 业绩预告相关的主要财务数据情况：经财务部门初步测算， 预计公司 2025 年度实现归属母公司所有者的净利润约为 1.4 亿元至 1.65 亿元，与上年同期相比，将实现扭亏为盈。预计 2025 年度实现 归属于母公司所有者的扣除非经常性损益后的净利润约为 1.35 亿元 至 1.6 亿元。 一、 本期业绩预告情况 （一）业绩预告期间： 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况： 经财务部门初步测算，预计公司 2025 年度实现归属母公司所有 者的净利润约为 1.4 亿元至 1.65 亿元，与上年同期相比，将实现扭 亏为盈。 预计 2025 年度实现归属于母公司所有者的扣除非经常性损益后 的净利润约为 1.35 亿元至 1.6 ...

南财智讯1月22日电，大名城发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润为1.4亿 元至1.65亿元，同比扭亏；预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润为1.35亿 元至1.6亿元，。归属于上市公司股东的净利润为1.4亿元至1.65亿元，归属于上市公司股东的净利润同 比扭亏，原因：（一）报告期内公司计提资产减值损失的金额同比2024年大幅减少，主要系影响公司计 提存货跌价准备及投资性房地产减值准备的因素已不再持续恶化。（二）报告期内公司依据杭州普润星 融股权投资合伙企业（有限合伙）出具的《杭州星融有限合伙人减资退伙清算分配通知书》，公司已完 成该项投资的全部退出及收回工作，已全额收到投资款8.048亿。本投资事项的完成，导致公司本报告 期的投资收益增加。 ...